Full-Time

Product Design Engineer

Confirmed live in the last 24 hours

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

No salary listed

Mid

Sydney NSW, Australia

In Person

Category
Product & UX/UI Design
UI/UX & Design
Required Skills
CAD
Product Design
SolidWorks
Requirements
  • Bachelor’s degree in Industrial Design, Product Design, or a related field.
  • Minimum of 3 years of experience in a product design role.
  • Proficiency in CAD software (e.g., Creo, SolidWorks, NX), preferably experience with surfacing.
  • Strong understanding of manufacturing processes, materials, and production techniques.
  • Excellent problem-solving skills and the ability to think creatively and strategically.
  • Excellent communication skills: both written and verbal, ability to clearly communicate design ideas, contribute to brainstorming.
Responsibilities
  • Utilise Design Thinking to navigate the discovery and delivery process.
  • Stay current with industry trends, emerging technologies, and best practices to drive innovation and maintain a competitive edge.
  • Conceptualise ideas through multiple mediums (sketches, low fidelity prototypes, rapid prototyping etc.).
  • Utilise 3D CAD to communicate detailed designs ensuring fit, form, and function (including tolerance analysis & DFMEA).
  • Conduct feasibility studies, create prototypes, and perform rigorous testing to validate design concepts.
  • Utilise 2D CAD tools to develop part specifications and technical drawings to communicate detailed designs with suppliers.
Desired Qualifications
  • Experience designing components for high volume manufacturing is preferred - specifically injection molded parts, liquid silicone rubber, cast and machined parts.

ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and COPD, as well as other chronic diseases. Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed serves patients, healthcare professionals, and caregivers, providing solutions that enhance care and improve quality of life. Unlike many competitors, ResMed focuses on both product sales and software subscriptions, which creates a steady revenue stream through recurring service fees. The company's goal is to reduce hospital visits and lower healthcare costs while addressing the needs of consumers and healthcare systems globally.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • The wearable health tech market expansion boosts ResMed's market penetration.
  • Rising demand for COPD management solutions presents growth opportunities for ResMed.
  • Telehealth expansion enhances ResMed's cloud-connected devices and software platforms.

What critics are saying

  • Emerging digital health startups may erode ResMed's market share.
  • Rapid technological advancements require continuous R&D investment, impacting profit margins.
  • Global semiconductor shortage could disrupt ResMed's production and supply chain.

What makes Resmed unique

  • ResMed integrates AI in sleep apnea diagnosis, enhancing accuracy and efficiency.
  • The company focuses on home-based care, aligning with industry trends.
  • ResMed's cloud-connected devices offer comprehensive remote patient monitoring solutions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

KirkpatrickPrice
May 6th, 2025
One Audit Firm, One Platform: Resmed's Journey to Settling Down

To bring consistency scalability, and simplicity to their audit engagements, Resmed partnered with KirkpatrickPrice.

GlobeNewswire
May 1st, 2025
Resmed Acquires Virtuox

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.The acquisition reflects Resmed’s commitment to improving the way care is delivered—by making it more accessible, more coordinated, and more patient friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a simpler, more connected way.VirtuOx’s virtual testing platform helps reduce barriers to diagnosis, offering fast, flexible, and affordable options for patients—particularly those with sleep-disordered breathing or other conditions that are often underdiagnosed. For people suspected of having obstructive sleep apnea (OSA), a more streamlined, digital-first experience can make the difference between following through on testing and treatment—or falling out of the care pathway entirely.“This is about creating a simpler, more connected pathway to care,” said Justin Leong, Chief Product Officer at Resmed. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.”This acquisition strengthens Resmed’s ability to partner with healthcare providers to help streamline the diagnostic process and alleviate current bottlenecks, while expanding collaboration with home medical equipment providers to efficiently and expeditiously support patients to start treatment. It further enhances the company’s ability to serve healthcare providers with integrated tools that improve care coordination, patient engagement, and outcomes.“VirtuOx and Resmed are aligned in our focus to simplify healthcare and expand access,” said Steve Lica, CEO of VirtuOx. “Joining Resmed gives us the opportunity to scale our impact, reach and help more patients, and keep innovating on behalf of the providers and health systems we serve.”The acquisition supports a growing demand for home-based care—driven by increased awareness, convenience, and digital innovation

IR Impact
Apr 24th, 2025
Resmed names Salli Schwartz as chief investor relations officer

Healthcare technology provider Resmed has named Salli Schwartz as its chief investor relations officer.

Veye
Apr 24th, 2025
Top ASX Stocks Get a Lift Post Strong Quarters

ResMed was also recognized as one of LexisNexis "Top 100 Global Innovators."

Fierce Biotech
Apr 4th, 2025
Resmed debuts wearable, at-home sleep apnea test

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.